This thoughtful approach supports your journey to improved well-being with confidence and ease
It belongs to a class of medications called GLP1/GIP dual agonists, or glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonists
Mol Psychiatry 28:284297 Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S, Carling D, Swann JR, Gibson G, Viardot A, Morrison D, Louise Thomas E, Bell JD (2014) The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Henriksen DB, Alexandersen P, Bjarnason NH, Vilsbll T, Hartmann B, Henriksen EE, et al
These figures reflect results from clinical trials of the active ingredients, not from Novi's program specifically
Still, one of the things your doctor will likely tell you is that theyre not for everyone